Glioblastoma: all 1,951 studies
Page 12 of 20. Open to participants first (457), then studies with results posted, then the rest; newest registration first within each.
- Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed GlioblastomaCompletedNCT04474353Phase 1
- Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBMCompletedNCT04471844Not applicable
- Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent GlioblastomaTerminatedNCT04469699Phase 2
- Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating FieldsActive, not recruitingNCT04469075Phase 2
- Trial of AEO in New Glioblastoma (GBM)Status unknownNCT04450160Phase 2
- Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM PatientsCompletedNCT04446416Not applicable
- Evaluation of GLR2007 for Advanced Solid TumorsCompletedNCT04444427Phase 1/2
- Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBMCompletedNCT04440358Phase 1/2
- Tumor Electric Fields Treatment System for GlioblastomaStatus unknownNCT04417933Early Phase 1
- Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin MonotherapyCompletedNCT04417088Phase 1/2
- Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed GlioblastomaTerminatedNCT04397679Phase 1
- LY3214996 Plus Abemaciclib in Recurrent Glioblastoma PatientsCompletedNCT04391595Early Phase 1
- Dose Finding for Intraoperative Photodynamic Therapy of GlioblastomaCompletedNCT04391062Phase 2
- Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.Status unknownNCT04388033Phase 1/2
- Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory GlioblastomaCompletedNCT04385173Phase 1
- A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511TerminatedNCT04327011Phase 1
- A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed GlioblastomaTerminatedNCT04324840Phase 1
- Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young AdultsActive, not recruitingNCT04323046Phase 1
- Expanded Access for KHK2455No longer availableNCT04321694
- Oral Gallium Maltolate for the Treatment of Relapsed and Refractory GlioblastomaActive, not recruitingNCT04319276Phase 1
- FDG and FDOPA PET Demonstration of Functional Brain AbnormalitiesStatus unknownNCT04315584Early Phase 1
- Comparison of Hypertonic Saline and Mannitol on Brain Relaxation During Supratentorial Tumors ResectionStatus unknownNCT04314674Not applicable
- A Explorative Study to Evaluate the Clinical Feasibility of AVATAMEDStatus unknownNCT04313842
- Individual Patient Compassionate Use of GX-I7No longer availableNCT04289155
- Immunohistochemical Assessment of Programmed Death ligand1 and LC3B in GBMStatus unknownNCT04284306
- Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in GlioblastomaCompletedNCT04280848Phase 2
- ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM)Status unknownNCT04277221Phase 3
- NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid TumorsWithdrawnNCT04270461Phase 1
- LAM561 With RT and TMZ for Adults With GlioblastomaActive, not recruitingNCT04250922Phase 2/3
- Supramarginal Resection in GlioblastomaActive, not recruitingNCT04243005Not applicable
- Repurposing Chlorpromazine in the Treatment of GlioblastomaStatus unknownNCT04224441Phase 2
- Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)SuspendedNCT04222309Phase 1
- Niraparib/TTFields in GBMActive, not recruitingNCT04221503Phase 2
- 18F-FluorThanatrace (PET/CT) in GlioblastomaTerminatedNCT04221061Early Phase 1
- Predicting Response Patterns to Treatment in Glioblastoma (GBM) PatientsSuspendedNCT04219475
- Effect of Timing of Tumor-Treating Fields Plus Short-Course RadiationWithdrawnNCT04218019Not applicable
- Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive GlioblastomaActive, not recruitingNCT04214392Phase 1
- Sulfasalazine and Stereotactic Radiosurgery for Recurrent GlioblastomaCompletedNCT04205357Phase 1
- Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent GlioblastomaCompletedNCT04201873Phase 1
- A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent GlioblastomaWithdrawnNCT04200066Phase 1
- WSD0922-FU for Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System MetastasesActive, not recruitingNCT04197934Phase 1
- Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBMActive, not recruitingNCT04195139Phase 2
- Safety and Tolerability of ABM-1310 in Patients With Advanced Solid TumorsTerminatedNCT04190628Phase 1
- LITT Followed by Hypofractionated RT for Recurrent GliomasActive, not recruitingNCT04181684Not applicable
- Utility of Primary Glioblastoma Cell LinesStatus unknownNCT04180046
- D2C7-IT With Atezolizumab for Recurrent GliomasCompletedNCT04160494Phase 1
- Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed GlioblastomaStatus unknownNCT04157478Phase 2
- A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational BurdenActive, not recruitingNCT04145115Phase 2
- Response Prediction for Anti-angiogenic Treatment in Recurrent GlioblastomaCompletedNCT04143425
- Function and Composition of Regulatory B Cells in Participants With GlioblastomaTerminatedNCT04128774
- Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated PatientsActive, not recruitingNCT04121455Phase 1/2
- Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed GlioblastomaCompletedNCT04119674Phase 1/2
- Abemaciclib + Pembrolizumab In GlioblastomaWithdrawnNCT04118036Phase 2
- A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma PatientsActive, not recruitingNCT04116411Phase 2
- Antisecretory Factor in Primary Glioblastoma 1CompletedNCT04116138Phase 1/2
- Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed GlioblastomaWithdrawnNCT04105374Phase 2/3
- Evaluate the Safety and Effectiveness of Intranasal Administration of Temozolomide in Patients With GlioblastomaCompletedNCT04091503Phase 1
- Abemaciclib w/Bevacizumab in Recurrent GBM Pts w/Loss of CDKN2A/B or Gain or Amplification of CDK4/6TerminatedNCT04074785Early Phase 1
- Efficacy and Safety Study of GX-I7 Plus Adjuvant Temozolomide Combination in Patients With Newly Diagnosed GlioblastomaWithdrawnNCT04065087Phase 1/2
- Regorafenib in Bevacizumab Refractory Recurrent GlioblastomaCompletedNCT04051606Phase 2
- Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPGActive, not recruitingNCT04049669Phase 2
- Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed GlioblastomaActive, not recruitingNCT04047706Phase 1
- CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and GlioblastomaTerminatedNCT04047303Phase 1
- CD147-CART Cells in Patients With Recurrent Malignant Glioma.Status unknownNCT04045847Early Phase 1
- Fluoroethyltyrosine for Evaluation of Intracranial NeoplasmsCompletedNCT04044937Phase 2
- The Registry of Oncology Outcomes Associated with Testing and TreatmentCompletedNCT04028479
- Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed GlioblastomaActive, not recruitingNCT04019262Phase 1/2
- Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With GlioblastomaCompletedNCT04019002Phase 1
- Surgically Induced Neurological Deficits in Glioblastomas (SIND Study)Active, not recruitingNCT04007185
- Clinical Study on the Treatment of Recurrent Glioblastoma With AnlotinibStatus unknownNCT04004975Phase 1/2
- IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBMActive, not recruitingNCT04003649Phase 1
- Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Recurrence Of Glioblastoma MultiformeTerminatedNCT04002804Phase 1
- Personalized Functional Profiling in Metastatic Gastrointestinal Cancer or Recurrent Glioblastoma Patients in Luxembourg.CompletedNCT03997617Not applicable
- Prognostic Impact of Surgical Resection Extent for Supratentorial High Grade Gliomas.Status unknownNCT03997136
- Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0CompletedNCT03995706Early Phase 1
- [18F]Fluciclovine in Post-treatment Glioblastoma ( Axumin )CompletedNCT03990285Phase 1
- Anti-Cancer Effects of Carvedilol With Standard Treatment in Glioblastoma and Response of Peripheral Glioma Circulating Tumor CellsWithdrawnNCT03980249Early Phase 1
- Memory Perception Assessment in Central/Non-central Nervous System CancersCompletedNCT03975959Not applicable
- Pediatric Long-Term Follow-up and Rollover StudyActive, not recruitingNCT03975829Phase 4
- Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade GliomasTerminatedNCT03971734Phase 1
- AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing SurgeryTerminatedNCT03965494Early Phase 1
- Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBMCompletedNCT03961971Phase 1
- Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant GliomasWithdrawnNCT03956706Not applicable
- Targeting Potassium Channels to Reprogram Glioblastoma Microenvironment: in Vitro and in Vivo StudiesStatus unknownNCT03954691
- Bioenergetic Profiling and Cognition in GBM PatientsTerminatedNCT03939858
- F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing SurgeryCompletedNCT03926507Not applicable
- Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in GlioblastomaCompletedNCT03922984Not applicable
- Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade GliomaActive, not recruitingNCT03919071Phase 2
- V-Boost Immunotherapy in Glioblastoma Multiforme Brain CancerStatus unknownNCT03916757Phase 2
- Feasibility Study of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT in Glioblastoma's PatientsStatus unknownNCT03903419Not applicable
- Pembrolizumab for Newly Diagnosed GlioblastomaActive, not recruitingNCT03899857Phase 2
- PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type GlioblastomaTerminatedNCT03897491Phase 2
- The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)Status unknownNCT03896958
- Fimepinostat in Treating Brain Tumors in Children and Young AdultsActive, not recruitingNCT03893487Early Phase 1
- Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGGCompletedNCT03879512Phase 1/2
- Validation of Readiband™ Actigraph and Associated Sleep/Wake Classification AlgorithmsCompletedNCT03877861
- NovoTTF-200A Together With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed GBMStatus unknownNCT03869242Not applicable
- A Study to Evaluate the Safety of LAM561 Added to Standard of Care in Newly-diagnosed Glioblastoma PatientsCompletedNCT03867123Phase 1
- A Study Evaluating Temferon in Patients With Glioblastoma & Unmethylated MGMTTerminatedNCT03866109Phase 1/2
- Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma PatientsCompletedNCT03865355